| Role of CD146 (MCAM) in physiological and pathological angiogenesis—contribution of new antibodies for therapy A Joshkon, X Heim, C Dubrou, R Bachelier, W Traboulsi, J Stalin, ... Biomedicines 8 (12), 633, 2020 | 40 | 2020 |
| PPARγ controls pregnancy outcome through activation of EG-VEGF: new insights into the mechanism of placental development V Garnier, W Traboulsi, A Salomon, S Brouillet, T Fournier, C Winkler, ... American Journal of Physiology-Endocrinology and Metabolism 309 (4), E357-E369, 2015 | 39 | 2015 |
| Antagonism of EG-VEGF Receptors as Targeted Therapy for Choriocarcinoma Progression In Vitro and In Vivo W Traboulsi, F Sergent, H Boufettal, S Brouillet, R Slim, P Hoffmann, ... Clinical Cancer Research 23 (22), 7130-7140, 2017 | 37 | 2017 |
| NLRP7 is increased in human idiopathic fetal growth restriction and plays a critical role in trophoblast differentiation R Abi Nahed, D Reynaud, AJ Borg, W Traboulsi, A Wetzel, V Sapin, ... Journal of molecular medicine 97, 355-367, 2019 | 33 | 2019 |
| Prokineticins in central and peripheral control of human reproduction W Traboulsi, S Brouillet, F Sergent, H Boufettal, N Samouh, ... Hormone molecular biology and clinical investigation 24 (2), 73-81, 2015 | 31 | 2015 |
| A novel anti-CD146 antibody specifically targets cancer cells by internalizing the molecule M Nollet, J Stalin, A Moyon, W Traboulsi, A Essaadi, S Robert, N Malissen, ... Oncotarget 8 (68), 112283, 2017 | 29 | 2017 |
| Inhibition of human placental endothelial cell proliferation and angiogenesis by netrin-4 M Dakouane-Giudicelli, S Brouillet, W Traboulsi, A Torre, G Vallat, ... Placenta 36 (11), 1260-1265, 2015 | 27 | 2015 |
| Therapeutic targeting of soluble CD146/MCAM with the M2J‐1 monoclonal antibody prevents metastasis development and procoagulant activity in CD146‐positive invasive tumors J Stalin, W Traboulsi, L Vivancos‐Stalin, M Nollet, A Joshkon, R Bachelier, ... International Journal of Cancer 147 (6), 1666-1679, 2020 | 23 | 2020 |
| Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma M Dufies, M Nollet, D Ambrosetti, W Traboulsi, J Viotti, D Borchiellini, ... Theranostics 8 (9), 2447, 2018 | 19 | 2018 |
| NLRP7 promotes choriocarcinoma growth and progression through the establishment of an immunosuppressive microenvironment D Reynaud, R Abi Nahed, N Lemaitre, PA Bolze, W Traboulsi, F Sergent, ... Cancers 13 (12), 2999, 2021 | 17 | 2021 |
| Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) and its receptor PROKR2 are associated to human colorectal cancer progression and peritoneal carcinomatosis M Benlahfid, W Traboulsi, F Sergent, M Benharouga, K Elhattabi, ... Cancer Biomarkers 21 (2), 345-354, 2018 | 15 | 2018 |
| EG-VEGF, BV8, and their receptor expression in human bronchi and their modification in cystic fibrosis: Impact of CFTR mutation (delF508) S Chauvet, W Traboulsi, L Thevenon, A Kouadri, JJ Feige, B Camara, ... American Journal of Physiology-Lung Cellular and Molecular Physiology 309 (3 …, 2015 | 14 | 2015 |
| Prokineticin 1 is a new biomarker of human oocyte competence: expression and hormonal regulation throughout late folliculogenesis N Alfaidy, C Baron, Y Antoine, D Reynaud, W Traboulsi, A Gueniffey, ... Biology of reproduction 101 (4), 832-841, 2019 | 10 | 2019 |
| Evidence-based view of safety and effectiveness of prokineticin receptors antagonists during pregnancy D Reynaud, F Sergent, R Abi Nahed, W Traboulsi, C Collet, C Marquette, ... Biomedicines 9 (3), 309, 2021 | 9 | 2021 |
| Soluble CD146 as a potential target for preventing Triple negative breast Cancer MDA-MB-231 cell growth and dissemination A Sharma, A Joshkon, A Ladjimi, W Traboulsi, R Bachelier, S Robert, ... International Journal of Molecular Sciences 23 (2), 974, 2022 | 8 | 2022 |
| Involvement of Multiple variants of soluble CD146 in Systemic Sclerosis: Identification of a novel profibrotic factor M Nollet, R Bachelier, A Joshkon, W Traboulsi, A Mahieux, A Moyon, ... Arthritis & rheumatology 74 (6), 1027-1038, 2022 | 7 | 2022 |
| Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastoma A Joshkon, E Tabouret, W Traboulsi, R Bachelier, S Simoncini, S Roffino, ... Acta Neuropathologica Communications 10 (1), 151, 2022 | 4 | 2022 |
| CD146-Positive Tumors are Associated with Venous Thromboembolism A Joshkon, J Stalin, W Traboulsi, L Vivancos-Stalin, M Nollet, R Lacroix, ... Journal of Cellular Immunology 2 (3), 116-123, 2020 | 3 | 2020 |
| Soluble CD146 is increased in preeclampsia and interacts with galectin-1 to regulate trophoblast migration through VEGFR2 receptor S Bouvier, W Traboulsi, SM Blois, C Demattei, A Joshkon, E Mousty, ... F&S Science 3 (1), 84-94, 2022 | 2 | 2022 |
| Vascular endothelial growth factor (VEGF) and Endocrine gland‐VEGF (EG‐VEGF) are down regulated in head and neck cancer SM Bouzoubaa, M Benlahfid, M Sidqui, T Aboussaouira, C Rifki, ... Clinical Otolaryngology 45 (5), 788-795, 2020 | 2 | 2020 |
